Centuri Names New CFO and Chief Legal Officer in Leadership Overhaul
CTRI sits 25% above its 52-week low of $19.04.
Summary
Centuri Holdings appointed Kelly Youngblood as CFO and Danielle Hunter as Chief Legal & Administrative Officer, replacing Gregory Izenstark and Jason Wilcock effective immediately. The dual C-suite change comes days after record Q2 results.
Key Events · Executive and Board Changes · CTRI
-
Dual C-Suite Appointments
Kelly Youngblood appointed EVP, CFO and Danielle Hunter appointed EVP, Chief Legal & Administrative Officer, both effective August 12, 2026, replacing Gregory Izenstark and Jason Wilcock.
-
CFO Compensation Package
Youngblood receives $680,000 base salary, 85% target bonus, 225% target LTI, and a $2.03 million sign-on RSU grant vesting over three years.
-
Departing Executives' Severance
Company expects to enter severance agreements with Izenstark and Wilcock providing termination without cause benefits per their existing employment agreements.
-
Timing After Record Q2
Leadership change announced eight days after Centuri reported record Q2 revenue of $962 million and raised full-year guidance.
Analysis · CTRI · Energy & Transportation
Centuri replaced both its CFO and Chief Legal Officer on the same day, bringing in Kelly Youngblood from DNOW/MRC Global and Danielle Hunter from Berry Corporation. The simultaneous departure of two C-suite executives is a significant governance event, especially coming just eight days after the company reported record Q2 results and raised guidance. The new CFO's compensation package includes a $2.03 million sign-on equity grant and severance terms that could pay up to two times salary plus bonus and LTI targets in a change-in-control scenario. The company is clearly investing in leadership to execute its Vision One Centuri strategy, but the abruptness of the dual transition warrants investor attention.
At the time of this filing, CTRI was trading at $23.77 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $19.04 to $42.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.